Passage BIO reported net income of -$7.82M for the quarter ended Jun 2026. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 2.70M | 2.71M | 2.72M | 2.72M | 2.73M | 2.73M | 2.73M | 2.74M | 2.74M | 2.75M | 3.08M | 3.09M | 3.09M | 3.10M | 3.11M | 3.18M | 3.18M | 3.18M | 3.21M | 3.22M | ||||||||||
| Operating items | ||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 26.62M | 32.97M | 26.21M | 26.82M | 15.36M | 17.66M | 16.84M | 17.32M | 15.10M | 12.16M | 11.54M | 10.43M | 8.66M | 9.56M | 7.74M | 5.81M | 4.31M | 5.42M | 4.09M | 3.34M | ||||||||||
| Selling, General & AdministrativeSG&A | 14.98M | 17.19M | 15.10M | 12.99M | 10.66M | 10.59M | 19.05M | 8.06M | 8.18M | 6.29M | 6.51M | 6.51M | 7.25M | 4.71M | 6.08M | 4.52M | 4.35M | 4.92M | 4.79M | 6.87M | ||||||||||
| Other Operating ExpensesOther Opex | 0.00M | 0.27M | 0.82M | 1.54M | 1.53M | 1.56M | 0.63M | 1.94M | ||||||||||||||||||||||
| Operating ExpensesOpex | 41.60M | 50.16M | 41.31M | 39.81M | 26.03M | 28.24M | 35.88M | 25.39M | 23.28M | 18.45M | 18.05M | 16.94M | 15.91M | 14.27M | 13.82M | 10.33M | 8.65M | 10.34M | 8.88M | 10.22M | ||||||||||
| Operating IncomeOp. Inc | -47.10M | -51.16M | -42.81M | -39.81M | -27.53M | -28.24M | -35.88M | -25.39M | -28.67M | -18.45M | -18.05M | -17.38M | -20.70M | -14.27M | -16.46M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| EBIT | -47.10M | -51.16M | -42.81M | -39.81M | -27.53M | -28.24M | -35.88M | -25.39M | -28.67M | -18.45M | -18.05M | -17.38M | -20.70M | -14.27M | -16.46M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||
| Non Operating Investment Income | ||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.19M | -0.74M | -0.92M | -0.24M | 0.11M | 0.50M | 0.54M | 0.09M | 0.15M | 0.15M | -0.03M | 0.00M | 0.10M | -0.02M | -0.01M | |||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 1.54M | 1.53M | 1.60M | 1.69M | 1.34M | 1.40M | 1.40M | 1.53M | 1.10M | 0.95M | 0.91M | 0.89M | 0.70M | 0.50M | ||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||
| EBT | -46.91M | -51.90M | -43.73M | -40.06M | -27.42M | -27.74M | -35.34M | -25.30M | -28.52M | -18.30M | -18.08M | -17.38M | -20.60M | -14.29M | -16.47M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Profit After TaxPAT | -46.91M | -51.55M | -43.73M | -39.79M | -26.70M | -26.57M | -34.34M | -23.86M | -27.11M | -16.76M | -16.74M | -15.99M | -19.34M | -12.72M | -15.41M | -9.40M | -7.75M | -12.98M | -7.60M | -7.82M | ||||||||||
| Income from Continuing OperationsIncome (Continuing) | -46.91M | -51.90M | -43.73M | -40.06M | -27.42M | -27.74M | -35.34M | -25.30M | -28.52M | -18.30M | -18.08M | -17.38M | -20.60M | -14.29M | -16.47M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Consolidated Net IncomeConsol Net Inc. | -46.91M | -51.90M | -43.73M | -40.06M | -27.42M | -27.74M | -35.34M | -25.30M | -28.52M | -18.30M | -18.08M | -17.38M | -20.60M | -14.29M | -16.47M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Income towards Parent CompanyParent Net Inc | -46.91M | -51.90M | -43.73M | -40.06M | -27.42M | -27.74M | -35.34M | -25.30M | -28.52M | -18.30M | -18.08M | -17.38M | -20.60M | -14.29M | -16.47M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Net Income towards Common StockholdersNet Income | -46.91M | -51.90M | -43.73M | -40.06M | -27.42M | -27.74M | -35.34M | -25.30M | -28.52M | -18.30M | -18.08M | -17.38M | -20.60M | -14.29M | -16.47M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| EPS (Basic) | -17.38 | -19.46 | -16.12 | -14.73 | -10.07 | -10.19 | -12.94 | -9.25 | -10.41 | -6.68 | -6.42 | -5.63 | -6.67 | -4.73 | -5.30 | -3.26 | -2.72 | -4.36 | -2.57 | -2.58 | ||||||||||
| EPS (Diluted) | -17.38 | -19.46 | -16.12 | -14.73 | -10.07 | -10.19 | -12.94 | -9.25 | -10.41 | -6.68 | -6.42 | -5.63 | -6.67 | -4.73 | -5.30 | -3.26 | -2.72 | -4.36 | -2.57 | -2.58 | ||||||||||
| Shares Outstanding | 2.70M | 2.67M | 2.71M | 2.72M | 2.72M | 2.72M | 2.73M | 2.73M | 2.74M | 2.74M | 2.81M | 3.08M | 3.09M | 3.02M | 3.11M | 3.17M | 3.18M | 3.17M | 3.21M | 3.21M | ||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 2.70M | 2.67M | 2.71M | 2.72M | 2.72M | 2.72M | 2.73M | 2.73M | 2.74M | 2.74M | 2.81M | 3.08M | 3.09M | 3.02M | 3.11M | 3.17M | 3.18M | 3.17M | 3.21M | 3.21M | ||||||||||
| EBITDA | -47.10M | -51.16M | -42.81M | -39.81M | -27.53M | -28.24M | -35.88M | -25.39M | -28.67M | -18.45M | -18.05M | -17.38M | -20.70M | -14.27M | -16.46M | -10.33M | -8.65M | -13.85M | -8.25M | -8.27M |